Hoekman J - Search Results

1

Nasal Delivery of Acute Medications for Migraine: The Upper Versus Lower Nasal Space.

Martin V, Hoekman J, Aurora SK, Shrewsbury SB. Martin V, et al. Among authors: hoekman j. J Clin Med. 2021 Jun 2;10(11):2468. doi: 10.3390/jcm10112468. J Clin Med. 2021. PMID: 34199479 Free PMC article. Review.

2

Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action.

Cooper W, Ray S, Aurora SK, Shrewsbury SB, Fuller C, Davies G, Hoekman J. Cooper W, et al. Among authors: hoekman j. J Aerosol Med Pulm Drug Deliv. 2022 Dec;35(6):321-332. doi: 10.1089/jamp.2022.0005. Epub 2022 Sep 14. J Aerosol Med Pulm Drug Deliv. 2022. PMID: 36108289 Free PMC article. Review.

3

STOP 101: A Phase 1, Randomized, Open-Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD^® ) Device, in Healthy Adult Subjects.

Shrewsbury SB, Jeleva M, Satterly KH, Lickliter J, Hoekman J. Shrewsbury SB, et al. Among authors: hoekman j. Headache. 2019 Mar;59(3):394-409. doi: 10.1111/head.13476. Epub 2019 Jan 19. Headache. 2019. PMID: 30659611 Clinical Trial.

4

Dihydroergotamine (DHE) - Then and Now: A Narrative Review.

Silberstein SD, Shrewsbury SB, Hoekman J. Silberstein SD, et al. Among authors: hoekman j. Headache. 2020 Jan;60(1):40-57. doi: 10.1111/head.13700. Epub 2019 Nov 17. Headache. 2020. PMID: 31737909 Free PMC article.

5

The SNAP 101 Double-Blind, Placebo/Active-Controlled, Safety, Pharmacokinetic, and Pharmacodynamic Study of INP105 (Nasal Olanzapine) in Healthy Adults.

Shrewsbury SB, Hocevar-Trnka J, Satterly KH, Craig KL, Lickliter JD, Hoekman J. Shrewsbury SB, et al. Among authors: hoekman j. J Clin Psychiatry. 2020 Jun 30;81(4):19m13086. doi: 10.4088/JCP.19m13086. J Clin Psychiatry. 2020. PMID: 32609960 Free article. Clinical Trial.

6

Positron Emission Tomography Assessment of the Intranasal Delivery Route for Orexin A.

Van de Bittner GC, Van de Bittner KC, Wey HY, Rowe W, Dharanipragada R, Ying X, Hurst W, Giovanni A, Alving K, Gupta A, Hoekman J, Hooker JM. Van de Bittner GC, et al. Among authors: hoekman j. ACS Chem Neurosci. 2018 Feb 21;9(2):358-368. doi: 10.1021/acschemneuro.7b00357. Epub 2017 Nov 7. ACS Chem Neurosci. 2018. PMID: 29035509

7

Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats.

Hoekman JD, Ho RJ. Hoekman JD, et al. Anesth Analg. 2011 Sep;113(3):641-51. doi: 10.1213/ANE.0b013e3182239b8c. Epub 2011 Jun 27. Anesth Analg. 2011. PMID: 21709146 Free PMC article.

8

Effects of localized hydrophilic mannitol and hydrophobic nelfinavir administration targeted to olfactory epithelium on brain distribution.

Hoekman JD, Ho RJ. Hoekman JD, et al. AAPS PharmSciTech. 2011 Jun;12(2):534-43. doi: 10.1208/s12249-011-9614-1. Epub 2011 Apr 26. AAPS PharmSciTech. 2011. PMID: 21519984 Free PMC article.

9

Intranasal delivery of growth differentiation factor 5 to the central nervous system.

Hanson LR, Fine JM, Hoekman JD, Nguyen TM, Burns RB, Martinez PM, Pohl J, Frey WH 2nd. Hanson LR, et al. Among authors: hoekman jd. Drug Deliv. 2012 Apr;19(3):149-54. doi: 10.3109/10717544.2012.657720. Epub 2012 Feb 22. Drug Deliv. 2012. PMID: 22353012

10

Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure.

Hoekman JD, Srivastava P, Ho RJ. Hoekman JD, et al. J Pharm Sci. 2014 Aug;103(8):2231-9. doi: 10.1002/jps.24022. Epub 2014 Jun 6. J Pharm Sci. 2014. PMID: 24909764 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page